Defect Engineering in Biomedical Sciences
Advanced Materials · 2023
DOI: 10.1002/adma.202304176 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, 2023. Verfasst von Meng Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, Ch…. Hauptthemen laut MEDLINE: Nanostructures, Nanoparticles. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 217 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, science and technology development plan of Jilin province.
Abstract (Originalsprache)
With the promotion of nanochemistry research, large numbers of nanomaterials have been applied in vivo to produce desirable cytotoxic substances in response to endogenous or exogenous stimuli for achieving disease‐specific therapy. However, the performance of nanomaterials is a critical issue that is difficult to improve and optimize under biological conditions. Defect‐engineered nanoparticles have become the most researched hot materials in biomedical applications recently due to their excellent physicochemical properties, such as optical properties and redox reaction capabilities. Importantly, the properties of nanomaterials can be easily adjusted by regulating the type and concentration of defects in the nanoparticles without requiring other complex designs. Therefore, this tutorial review focuses on biomedical defect engineering and briefly discusses defect classification, introduction strategies, and characterization techniques. Several representative defective nanomaterials are especially discussed in order to reveal the relationship between defects and properties. A series of disease treatment strategies based on defective engineered nanomaterials are summarized. By summarizing the design and application of defective engineered nanomaterials, a simple but effective methodology is provided for researchers to design and improve the therapeutic effects of nanomaterial‐based therapeutic platforms from a materials science perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China.
- Zanjan Pharmaceutical Nanotechnology Research Center (ZPNRC), and Department of Pharmaceutical Nanotechnology (School of Pharmacy), Zanjan University of Medical Sciences, Zanjan, 45139-56184, Iran.
- Department of Bio-Technology, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Andhra Pradesh, 522502, India.
- Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, 1417614411, Iran.
- Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin, 150001, China.
ORCID-Profile: Jun Lin
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- science and technology development plan of Jilin province
Zitieren
APA
Yuan, M., Kermanian, M., Agarwal, T., Yang, Z., Yousefiasl, S., Cheng, Z., Ma, P., Lin, J., & Maleki, A. (2023). Defect Engineering in Biomedical Sciences. Advanced Materials. https://doi.org/10.1002/adma.202304176
Vancouver
Yuan M, Kermanian M, Agarwal T, Yang Z, Yousefiasl S, Cheng Z, et al. Defect Engineering in Biomedical Sciences. Advanced Materials. 2023. doi:10.1002/adma.202304176
BibTeX
@article{Yuan2023,
author = {Yuan, Meng and Kermanian, Mehraneh and Agarwal, Tarun and Yang, Zhuang and Yousefiasl, Satar and Cheng, Ziyong and Ma, Ping'an and Lin, Jun and Maleki, Aziz},
title = {Defect Engineering in Biomedical Sciences},
journal = {Advanced Materials},
year = {2023},
doi = {10.1002/adma.202304176}
}
EUVIMED